As the incidence of genetic disorders increases, there is a corresponding rise in the demand for molecular biology enzymes, kits, and reagents essential for conducting tests. These tools are vital for ...

As of 2023 year-end, the firm had $1.2 billion of debt, $1.6 billion of cash and cash equivalents, and $1.5 billion of deferred taxes that are largely related to its Sartorius investment. We forecast ...

Inc. (NYSE: BIO and BIO.B), a $8.49 billion market cap company known for its life science research and clinical diagnostics products, has announced plans to acquire Stilla Technologies, a developer of ...

Laboratories “announced that the company has entered into a binding offer to purchase all equity interests in Stilla ...

It’s a respiratory infection that tends to get the most airtime among parents of infants, as young children are especially likely to catch it and have a bad case. But adults can certainly get it, too.

Recent study results show that the single-target DNA methylation test performed with a negative predictive value of 97.6 percent.

Guardant Health is overcoming skepticism with new cancer tests. Learn why GH stock is a buy, with strong growth and a shift ...

Mold contamination of cannabis sold in Massachusetts is far more common than state regulators have acknowledged, according to some labs tasked with testing the products.

A new retrospective, laboratory-based observational study provides detailed insights into the causes of fevers of unknown ...